Dr. Lori Muffly, MD
Claim this profileStanford University
Studies Leukemia
Studies Acute Myeloid Leukemia
10 reported clinical trials
15 drugs studied
Area of expertise
1Leukemia
CD33 positive
CD19 positive
HLA-A negative
2Acute Myeloid Leukemia
CD33 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Lori Muffly, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting1 award Phase 1
CAR T-Cell Therapy
for Leukemia
This trial is testing a treatment that uses special immune cells from a donor, modified to target and kill cancer cells, in adults with a specific type of blood cancer. These cells act like guided missiles, finding and destroying cancer cells by recognizing specific markers.
Recruiting1 award Phase 1
More about Lori Muffly, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Lori Muffly, MD has experience with
- Cyclophosphamide
- VCAR33
- CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells
- NKTR-255
- Fludarabine Phosphate
- Allogeneic Donor-derived T-cells Transduced With Bivalent Lentiviral Vector (CD19/CD22-BBz) Chimeric Antigen Receptor (CAR)
Breakdown of trials Lori Muffly, MD has run
Acute Myeloid Leukemia
Lymphoblastic Leukemia-Lymphoma
Acute Lymphoblastic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lori Muffly, MD specialize in?
Lori Muffly, MD focuses on Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Leukemia has involved CD33 positive patients, or patients who are CD19 positive.
Is Lori Muffly, MD currently recruiting for clinical trials?
Yes, Lori Muffly, MD is currently recruiting for 4 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Lori Muffly, MD has studied deeply?
Yes, Lori Muffly, MD has studied treatments such as Cyclophosphamide, VCAR33, CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells.
What is the best way to schedule an appointment with Lori Muffly, MD?
Apply for one of the trials that Lori Muffly, MD is conducting.
What is the office address of Lori Muffly, MD?
The office of Lori Muffly, MD is located at: Stanford University, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.